Cytokeratin contents of basal cell carcinoma, epidermis overlying tumour, and associated stromal amyloidosis: An immunohistochemical study

References

• Touart DM, Sau P. Cutaneous deposition diseases. Part I. J Am Acad Dermatol 1998;39:149–171.
   PubMedGoogle Scholar
• Inoue K, Takahashi M, Hamamoto Y, Muto M, Ishihara T. An immunohistochemical study of cytokeratins in skin-limited amyloidosis. Amyloid: Int J Exp Clin Invest 2000;7:259–265.
   PubMed Web of Science ®Google Scholar
• Romero LS, Kantor GR, Levin MW, Vonderheid EC. Localized cutaneous amyloidosis associated with mycosis fungoides. J Am Acad Dermatol 1997;37:124–127.
   PubMed Web of Science ®Google Scholar
• Miller SJ. Biology of basal cell carcinoma (Part I). J Am Acad Dermatol 1991;24:1–13.
   PubMed Web of Science ®Google Scholar
• Markey AC, Lane EB, Macdonald DM, Leigh IM. Keratin expression in basal cell carcinomas. Br J Dermatol 1992;126:154–160.
   PubMedGoogle Scholar
• Lavrijsen APM, Tieben LM, Ponec M, van der Schroeff JG, van Muijen GNP. Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin. Arch Dermatol Res 1989;281:83–88.
   PubMedGoogle Scholar
• Olsen KE, Westermark P. Amyloid in basal cell carcinoma and seborrheic keratosis. Acta Derm Venereol 1994;74:273–275.
   PubMedGoogle Scholar
• Looi LM. Localized amyloidosis in basal cell carcinoma. Cancer 1983;52:1833–1836.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Ito K, Taniguchi Y, Yang F, Younberg G. Keratin in cutaneous amyloidoses. Clin Dermatol 1990;2:55–65.
   Google Scholar
• Irvine AD, McLean WHI. Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 1999;140:815–828.
   PubMed Web of Science ®Google Scholar
• Hsu TM, Kwok PY. Advances in molecular medicine. J Am Acad Dermatol 2001;44:847–855.
   PubMedGoogle Scholar
• Steinert PM. Structure, function, and dynamics of keratin intermediate filaments. J Invest Dermatol 1993;100:729–734.
   PubMed Web of Science ®Google Scholar
• Yamamoto O, Asahi M. Cytokeratin expression in trichoblastic fibroma (small nodular type trichoblastoma), trichoepithelioma and basal cell carcinoma. Br J Dermatol 1999;140:8–16.
   PubMedGoogle Scholar
• Eto H, Hashimoto K, Kobayashi H, Fukaya T, Matsumoto M, Sun TT. Differential staining of cytoid bodies and skin-limited amyloids with monoclonal anti-keratin antibodies. Am J Pathol 1984;116:473–481.
   PubMedGoogle Scholar
• Kobayashi H, Hashimoto K. Amyloidogenesis in organ-limited cutaneous amyloidosis: an antigenic identity between epidermal keratin and skin amyloid. J Invest Dermatol 1988; 80:66–72.
   Google Scholar
• Chang YT, Liu HN, Wang WJ, Lee DD, Tsai SF. A study of cytokeratin profiles in localized cutaneous amyloids. Arch Dermatol Res 2004;296:83–88.
   PubMedGoogle Scholar
• Moll R, Franke WW, Schiller DL. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11–24.
   PubMed Web of Science ®Google Scholar
• Habets JM, Tank B, Vuzevski VD, Breve J, Stolz E, van Joost T. Absence of cytokeratin 8 and inconsistent expression of cytokeratins 7 and 19 in human basal cell carcinoma. Anticancer Res 1988;8:611–616.
   PubMedGoogle Scholar
• Poniecka AW, Alexis JB. An immunohistochemical study of basal cell carcinoma and trichoepithelioma. Am J Dermatopathol 1999;21:332–336.
   PubMedGoogle Scholar
• Schirren CG, Rütten A, Kaudewitz P, Diaz C, McClain S, Burgdorf WHC. Trichoblastoma and basal cell carcinoma are neoplasms with follicular differentiation sharing the same profile of cytokeratin intermediate filaments. Am J Dermatopathol 1997;19:341–350.
   PubMedGoogle Scholar
• Perkins W, Campbell I, Leigh IM, MacKie RM. Keratin expression in normal skin and epidermal neoplasms demonstrated by a panel of monoclonal antibodies. J Cutan Pathol 1992;19:476–482.
   PubMedGoogle Scholar
• Kikuchi A, Sakuraoka K, Shimizu H, Nishikawa T. Immunohistochemical evaluation of epidermis overlying basal cell carcinomas. Br J Dermatol 1993;128:644–649.
   PubMedGoogle Scholar
• Thomas P, Said JW, Nash G, Banks-Schlegel S. Profiles of keratin proteins in basal and squamous cell carcinomas of the skin. An immunohistochemical study. Lab Invest 1984;50:36–41.
   PubMedGoogle Scholar
• Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M. Keratins and keratinocyte activation cycle. J Invest Dermatol 2001;116:633–640.
   PubMed Web of Science ®Google Scholar
• Satti MB, Azzopardi JG. Amyloid deposits in basal cell carcinoma of the skin. A pathologic study of 199 cases. J Am Acad Dermatol 1990;22:1082–1087.
   PubMedGoogle Scholar
• Apaydin R, Gurbuz Y, Bayramgurler D, Muezzinoglu B, Bilen N. Cytokeratin expression in lichen amyloidosus and macular amyloidosis. JEADV 2004;18:305–309.
   Google Scholar